Ready for New Discoveries?

– Partner with a CRO you can count on

About Redoxis

Decision-enabling preclinical research in inflammation and immune-mediated diseases

Redoxis is a specialized preclinical CRO in Lund, Sweden, providing integrated in vitro, in vivo and high-resolution biology services. We design tailored studies to evaluate therapeutic efficacy, mechanism of action, PK/PD and translational biomarkers.

We focus on preclinical drug development and efficacy evaluation in models of inflammation and autoimmune disease. Rooted in academic research and driven by deep immunological expertise, we continuously advance and refine our portfolio of in vivo, ex vivo, and in vitro models to reflect the latest developments in translational immunology.

At Redoxis, every study is thoughtfully designed around your scientific question, therapeutic modality, and development phase. We combine mechanistic insight, rigorous execution, and transparent communication to generate robust, decision-enabling data.

Our scientists work closely with customers throughout the project—from study design and model selection to data interpretation and next-step recommendations. The result is scientifically robust, decision-enabling data that help development teams move forward with greater confidence.

In Vitro & Ex Vivo services

Services

Human and murine immune-cell assays, functional profiling, target validation, mechanism-of-action studies, cytokine analysis, flow cytometry, ELISpot and FluoroSpot. At Redoxis, we design scientifically tailored assays aligned with your biological question, therapeutic modality, and development phase. From pathway modulation and cytokine profiling to advanced immune cell phenotyping, our work is grounded in translational relevance and immunological expertise.

In Vivo Services

Services

Tailored efficacy and PK/PD studies using established models of rheumatoid arthritis, multiple sclerosis, lupus, inflammatory bowel disease, psoriasis, psoriatic arthritis and acute inflammation. At Redoxis, we specialize in well-characterized models of inflammation and autoimmune disease. Each study is thoughtfully designed around your mechanism of action, therapeutic modality, and development goals — ensuring biologically relevant and decision-enabling outcomes.

High-Resolution Biology

Services

Histology, immunohistochemistry, whole-slide imaging, quantitative image analysis and single-cell and spatial biology approaches. At Redoxis, we combine quantitative histopathology, advanced imaging platforms, and single-cell transcriptomic analysis to deliver multidimensional data with translational relevance. From tissue architecture and immune infiltration to pathway-specific cellular signatures, our approaches strengthen mechanistic understanding and support confident decision-making.

Customer Reviews

  • \"Redoxis has been a valuable collaborator in our studies. Their expertise, reliability and effective study execution are an asset!\"

    Sushrusha Nayak, Manager Preclinical

    Chiesi

  • \"Professional services with customer focus.\"

    Eskil Söderlind

    Merozyne, Sweden

  • \"BCI collaborates with Redoxis for many years and we really appreciate study discussions, planning, flexibility and study reports. Redoxis is a really competitive and expert CRO for in-vivo and in-vitro studies and with the sense of urgency. I really recommend to use their platform and expertise.\"

    Dominique Surleraux, President and CEO

    BCI Pharma

More Reviews

Contact us

Inquiries? Questions?

Nina Woodworth

COO